Pr Remy Burcelin, PhD
Chairman and Founder
Pr. Burcelin is a Research Director at the French national medical research institute (INSERM), where he has focused since 2007 on the molecular bases of insulin resistance and the role of the intestine (microflora & endocrine function) in the control of metabolic diseases. Dr Burcelin is an internationally renowned specialist on glucoincretins (GLP-1 and GIP). From 2000 to 2003 he was Assistant Professor at the Institute of Pharmacology and Toxicology headed by Professor B. Thorens in Lausanne, Switzerland. Mr. Burcelin gained his PhD in molecular endocrinology in 1992 and completed his studies at Institut Jacque Monod (Paris, France) and the Albert Einstein College of Medicine (Prof. M.J. Charron, New York, USA). He also led a research program at Modex Therapeutic (CH, Lausanne) in 1997. In 2002 he received a prestigious award (“Apolinaire Bouchardat”) for his research on diabetes. Mr. Burcelin is a member of the editorial board of Endocrinology, a reviewer for major journals in diabetes, and an advisor to many international pharmaceutical companies. He is also a member of several international societies, such as the French, European and American associations for the study of diabetes (ALFEDIAM, EFSD and ADA). Mr. Burcelin has authored more than 80 publications in international journals.
Dr Luc Pénicaud, PhD
Member and Founder
Dr. Pénicaud has been a Research Director at the Centre National de la Recherche Scientifique (CNRS) since 1989. From 1995 to 2007, Dr. Pénicaud was director of a CNRS unit affiliated to the University of Toulouse. Earlier, he was CNRS team leader in the Nutrition Laboratory at Paris VI University. He earned his PhD from Paris VI and VII Universities and completed his postdoctoral studies at the University of Rochester NY, USA, the University Medical Center, Geneva, Switzerland, and the Nutrition Center, Paris. He is the recipient of several awards for his research in neurobiology and energy homeostasis in diabetes and obesity. Dr. Pénicaud is a member of several international societies, such as the European Association for the Study of Diabetes (EASD), the American Diabetes Association (ADA), the European Association for the Study of Obesity (EASO), and the European and International Society of Neuroscience. He is a member of the Scientific Commission on Physiology at CNRS, the Scientific Board at the Institut National de la Recherche Agronomique (INRA), the Scientific Board of the Nutrition Department of the same Institute, and the Commission of the French National Program on Diabetes. Dr. Pénicaud is the author of over 160 scientific publications and is regularly invited to speak at national and international meetings.
Pr Louis Casteilla PhD, MSc
Member and Founder
Pr. Louis Casteilla has been a professor at Toulouse university since 1992. From 1992 to 2007, Dr. Casteilla led a team on adipose tissue plasticity at a CNRS unit affiliated to the University of Toulouse. Earlier, Dr. Casteilla held an INRA position in the Laboratory of Molecular Endocrinology (Meudon, France) and the Rodent Research Center in Theix, France. He earned his PhD from the University of Nice (Biochemistry Institute) and completed postdoctoral studies at the Laboratory of Molecular Endocrinology, Meudon, France. He recently spent a year as invited professor at Pittsburgh Children’s Hospital (USA). Mr Casteilla is a member of several international societies, such as the European Association for the Study of Obesity (EASO), and the International Federation of Adipose Therapeutics of Science. He is the author of over 90 scientific publications, holds several patents in the field of metabolism and cell therapy, and is regularly invited to speak at national and international meetings.
Pr Xavier Leverve, MD, PhD
Member
Pr. Leverve is Scientific Director for Human Nutrition and Food Safety at the National Institute of Agronomic Research in France. He is also Professor of Medicine (Nutrition and Intensive Care, Department of Acute Medicine) at Université Joseph Fourier, and is Director of INSERM research unit U884 (Bioénergétique Fondamentale et Appliquée). Xavier is qualified in Internal Medicine, Medical Intensive Care and Human Nutrition. He also has a PhD in Human Biology and Biochemistry. He is currently the Chairman of Conseil National des Universités (CNU) 44th section, 4th subsection (nutrition). He works intensively on the role of mitochondria in the biology of different cell types and organs in physiological and pathological states, including the effects of therapeutics molecules as metformin on mitochondrial functions.
Pr Jean Girard, PhD
Member
Pr. Girard is Professor of Biochemistry at the Faculty of Medicine of the University Paris-Descartes. He has been Chairman of the department of metabolism and endocrinology at the Cochin institute (Paris) from to 2002 to2007. For 12 years Pr. Girard has been director of the research center for molecular endocrinology and development (Meudon, Paris). Pr. Girard initiated his career in physiology at the University of Paris then at the College de France where he get his Ph D. Pr Girard is an internationally renowned specialist on the hormonal control of carbohydrate and lipid metabolisms. He has identified the molecular basis of the action of insulin and glucose for the control of lipogenesis. These features had major impact for the understanding of metabolic diseases diabetes, obesity, insulin resistance and hepatic steatosis. Several prestigious awards recognize excellence of his forty years’ research on the physiological and molecular bases of glucose homeostasis : Robert Denamur Award (INRA, 1976), Apollinaire Bouchardat Award (1979), Docteur and Mme Labbe (Académie des Sciences (1981), Antoine Lacassagne (Collège de France, 1982), Fondation Française pour la Nutrition (1990). He is corresponding member of the French Académy of Sciences. He was past Chairman of the ALFEDIAM (French association for the study of diabetes). He has been member of the editorial board of major scientific journals (Diabetes, Diabetologia, Biochemical Journal, European Journal of Biochemistry, Diabetes Obesity and Metabolism, Diabète & Métabolisme) and advisor to many international pharmaceutical companies (Sanofi-Aventis, Novo-Nordisk, GlaxoSmith Kline, Novartis, Merk-Scharp & Dohme). Pr. Girard is a member of several international societies, such as the French, European and American associations for the study of diabetes (ALFEDIAM, European Association for the Study of Daiabetes and American Diabetes Association). He has been member for 5 years in the Scientific Committee of the Juvenile Diabetes Fondation. Pr. Girard has authored close to 300 publications in international peer journals.